ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eye

Article

Sanjay N. Rao, MD, director of Refractive, Cornea and Advanced Anterior Segment Surgery at Dekalb Eye Consultants LLC, speaks with Ophthalmology Times' David Hutton on his presentation "Evaluation of intraoperative use of dexamethasone intraocular suspension, 9% (DEXYCU) on signs and symptoms of dry eye," during the 2020 ASCRS virtual conference.

 

See more ASCRS coverage here 

Recent Videos
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Andrew Pucker, OD, PhD
Video 1 - "Challenging the Definition of Dry Eye- Interpreting Diagnostic Tests"
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
© 2024 MJH Life Sciences

All rights reserved.